Under-treatment of Depression in Older Persons by Barry, Lisa C.
University of Connecticut
OpenCommons@UConn
UCHC Articles - Research University of Connecticut Health Center Research
2-2012
Under-treatment of Depression in Older Persons
Lisa C. Barry
University of Connecticut School of Medicine and Dentistry
Follow this and additional works at: https://opencommons.uconn.edu/uchcres_articles
Part of the Medicine and Health Sciences Commons
Recommended Citation
Barry, Lisa C., "Under-treatment of Depression in Older Persons" (2012). UCHC Articles - Research. 166.
https://opencommons.uconn.edu/uchcres_articles/166
Under-treatment of Depression in Older Persons
Lisa C. Barry, Ph.D., M.P.H.1, Janet J. Abou, M.D.2, Arthur A. Simen, M.D., Ph.D3, and
Thomas M. Gill, M.D.4
1UConn Center on Aging, University of Connecticut Health Center, Farmington, Connecticut
2University of California Los Angeles Medical Center, Los Angeles, California
3Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
4Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
Abstract
Background—Due to the cross-sectional design of most existing studies, longitudinal
characterization of treatment for depression in older persons is largely unknown.
Method—754 men and women (aged 70+ years) underwent monthly assessments of mental
health professional use and 18-month assessments of antidepressant medication use and depressive
symptoms over 9 years. Scores of ≥20 on the Center for Epidemiological Studies-Depression
(CES-D) scale denoted depression. We evaluated trends in depression treatment over time in the
entire sample and among the depressed participants. Using generalized linear models, we
determined characteristics associated with receiving treatment for depression in these groups and
among those with persistent depression.
Results—During the 9-year follow-up period (1998–2007), 339 (45.0%) of the participants
reported depression treatment. Over time, antidepressant use alone decreased (p trend <0.001)
while treatment with both antidepressants and a mental health professional increased (p trend =
0.002). Of the 286 (27.9%) depressed participants, between 43% and 69% did not receive
depression treatment during any 18-month interval. 30.5% of the 121 participants with persistent
depression did not receive treatment during the study period. Increasing number of years of
education, decreasing cognitive status score, and being physically frail were associated with a
higher likelihood of receiving treatment in all models.
Limitations—Pre-baseline depression, pre-baseline treatment, and indication for treatment were
unavailable.
Conclusions—Our findings indicate that the profile of treatment for depression in older persons
has changed over time, that depressed older persons, including those with persistent depression,
are under-treated, and that patient characteristics influence receipt of treatment.
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Background
Whereas major depression affects only about 1% to 2% of community-dwelling persons
aged 65 years or older (Blazer, 2003), clinically significant depressive symptoms are more
common. Often referred to as “depressed mood” or simply “depression,” clinically
significant depressive symptoms affect between 8% to 20% of this population (Blazer,
2003). Both major depression and depressive symptoms are associated with increased
healthcare costs (Katon et al., 2003) and adverse outcomes, including exacerbation of
coexisting medical illness, disability in activities of daily living, and mortality (Carnethon et
al., 2007; Penninx et al., 1999; Unutzer et al., 2002). Because many antidepressant
medications are safe and well-tolerated in older persons (Mamdani et al., 2000; Sonnenberg
et al., 2008), they are considered a first-line treatment for a spectrum of depressive disorders
in this population, including clinically significant depressive symptoms (Alexopoulos et al.,
2001). Receiving therapy from a mental health professional, such as a psychiatrist,
psychologist, or counselor, also has been found to be effective in treating depression in this
population (Cuijpers et al., 2006; Pinquart et al., 2006). A growing body of evidence,
however, indicates widespread under-treatment of depressive disorders in older persons.
This finding seems to be consistent across populations, including those who are community-
dwelling (Garrido et al., 2011; Sonnenberg et al., 2008; Unutzer et al., 2003; Wilson et al.,
1999), hospitalized (Koenig and George, 1998), or residing in a nursing home (Streim et al.,
2000). Yet, with few exceptions (Unutzer et al., 2003), prior studies evaluating treatment of
depression in older persons largely have evaluated either the use of antidepressant
medications or psychotherapy, but not both. Furthermore, due to the cross-sectional design
of most prior studies (Garrido et al., 2011; Mamdani et al., 2000; Sonnenberg et al., 2003;
Unutzer et al., 2003), the extent of potential under-treatment of older persons with
depression, including persistent depression, is largely unknown.
We sought to describe the profile of depression treatment (i.e., antidepressant medication
use and use of a mental health professional) over time in a large cohort of older persons. In
addition, to better understand the scope of potential under-treatment of depression in older
persons, we set out to characterize treatment in depressed, older persons over time and to
identify factors associated with potential under-treatment. To accomplish these aims, we
used data from a unique longitudinal study that includes up to six assessments of depressive
symptoms and antidepressant use at 18-month intervals and monthly assessments of mental
health professional use for 9 years.
Methods
Study Population
Participants were members of the Precipitating Events Project (PEP), a longitudinal study of
754 initially non-disabled, community-living persons aged 70 years or older (Gill et al.,
2001). Participants were identified from 3,157 age-eligible members of a health plan in New
Haven, Connecticut. The primary inclusion criteria were English speaking and requiring no
personal assistance with bathing, dressing, transferring from a chair, and walking across a
room. The participation rate was 75.2% (Gill et al., 2001). The Human Investigation
Committee at Yale University approved the study.
Data collection
Beginning on March 23, 1998, comprehensive face-to-face assessments were completed at
baseline and subsequently at 18-month intervals for 90 months, while telephone interviews
were completed monthly for up to 108 months. Deaths were ascertained from the local
obituaries and/or from an informant during a subsequent telephone interview. Four hundred
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and five (53.7%) participants died (median follow-up of 68 months) and 35 (4.6%) dropped
out of the study (median follow-up of 24 months). Consequently, there were 754, 681, 628,
559, 495, and 439 participants available at the baseline, 18-month, 36-month, 54-months,
72-month, and 90-month assessments, respectively.
During the baseline assessment, data were collected on demographic factors, including age,
sex, race, and years of education. During each of the comprehensive assessments, data were
collected on three important clinical factors. Medical comorbidity was ascertained based on
a count of up to nine self-reported, physician-diagnosed chronic conditions: hypertension,
myocardial infarction, congestive heart failure, stroke, diabetes mellitus, arthritis, hip
fracture, chronic lung disease, and cancer. Cognitive status was assessed by the Folstein
Mini-Mental State Examination (MMSE), where MMSE scores range from 0 to 30, with
higher scores representing better cognitive status (Folstein et al., 1975). Physical frailty was
assessed using a rapid gait test in which participants were instructed to walk a 10-foot
(3.048-m) course “as fast as it feels safe and comfortable,” turn around, and walk back.
Participants who completed the task in >10 seconds were considered to be physically frail
(Gill et al., 1995).
Depressive symptoms—Depressive symptoms were assessed using the 11-item Center
for Epidemiological Studies-Depression scale (CES-D) (Beekman et al., 1997; Kohout et al.,
1993). Scores were transformed to be compatible with the 20-item CES-D (Kohout et al.,
1993). Total scores range from 0 to 60, with higher scores indicating more depressive
symptoms. Participants scoring ≥20 were considered as having “clinically significant
depressive symptoms” or “depressed.” A CES-D score of 20 or higher has previously been
shown to enhance the likelihood of detecting major depression among community-living
older persons (Beekman et al., 2002). Data on depressive symptoms were complete for
100% of the participants at baseline and 95%, 93%, 91%, 90%, and 89% of the non-
decedents at 18, 36, 54, 72, and 90 months, respectively. Furthermore, “persistent
depression” was defined as having a CES-D score ≥20 during 2 consecutive face-to-face
assessments.
Depression Treatment—During the face-to-face assessments, participants were asked to
retrieve all of their medications. If a medication was not retrieved, the nurse asked to see the
participant’s medication list. If a list was unavailable, participants were asked to recall
medications that they had taken during the prior two weeks. All medications, but not the
doses or dosing schedule, were recorded. Participants were coded as having taken an
antidepressant medication based on a code of 28.16.04 from the American Hospital
Formulary System (AHFS). Because trazodone and amitriptyline were commonly used
during the study period for other indications, including sleep and pain (Mayers et al., 2005;
Saarto and Wiffen, 2007), antidepressant medication use was assessed with and without
these medications included. In addition, during the monthly assessments, participants were
asked “Since we last talked, have you seen a psychiatrist, psychologist, or counselor?”
Because the indication for use of a mental health professional was not ascertained, we used a
conservative approach to assessing this type of treatment for depression. If a participant
responded “yes” to the aforementioned question during any of the monthly assessments in a
given 18-month interval (e.g., between the 18-month and 36-month assessments), s/he was
coded as having seen a mental health professional for depression during that interval. This
rather inclusive definition enabled us to report the potential maximum percentage of
participants being treated for depression. Participants were subsequently assigned to one of
four treatment categories during each interval: having taken an antidepressant medication
only, having seen a mental health professional only, having both taken an antidepressant
medication and seen a mental health professional, and having received neither treatment.
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Statistical analysis
During each of the 6 intervals, we determined the percentage of all participants who
received depression treatment. Using Cochran-Armitage tests for trend, we then evaluated
trends over time in the percentage of participants receiving antidepressants only, seeing a
mental health professional only, or using both treatments. We then ran generalized linear
models using a generalized estimating equation approach, where CES-D score, medical
comorbidity, cognitive status, and physical frailty were entered as time-varying covariates,
to determine the characteristics associated with receiving treatment for depression. We
repeated this procedure among those who were depressed (i.e., CES-D score ≥20) at the
start of an 18-month interval, but excluded CES-D score from the statistical model. In
addition, we determined the percentage of participants who were depressed during at least 2
consecutive intervals (i.e., persistent depression), yet never reported receiving treatment for
depression and used the same modeling approach as was indicated for all depressed
participants. All statistical tests were 2-tailed, and P<0.05 was considered statistically
significant. Analyses were performed used using SAS statistical software, version 9.2.
Results
Description of the Sample
Table 1 presents the baseline characteristics of the sample. The mean age was 78.4 ± 5.3
years; two-thirds of the participants were women, 90.4 % were white, and 25.7% were
physically frail. On average, participants had 1.8 ± 1.2 chronic conditions and an MMSE
score of 26.8 ± 2.5. There were 100 (13.3%) participants who were depressed (i.e., CES-D
≥20).
Depression Treatment Over Time in the Entire Sample
During the 108-month study period, 339 (45.0%) participants reported receiving depression
treatment. After the exclusion of trazodone or amitriptyline, this number decreased to 319
(42.3%) participants. Overall, the percentage of participants receiving any depression
treatment, including trazodone or amitriptyline, increased over time (p trend <0.001), with
112 (14.9%), 120 (17.6%), 140 (22.3%), 146 (26.2%), 142 (28.7%), and 160 (36.4%) of the
sample receiving treatment during the six 18-month intervals from baseline to 108 months.
Figure 1 presents the profile of depression treatment, among the participants receiving
treatment, during each interval throughout the study. Whereas antidepressant use alone was
the most common depression treatment reported, the percentage of participants who reported
taking antidepressant medications only decreased over time (p trend <0.001). In contrast,
there was an increase over time in the percentage of participants receiving both treatments
(i.e., antidepressant medications and seeing a mental health professional) (p=0.002). The
percentage of participants seeing a mental health professional only increased over time, but
the trend was non-significant.
Among the participants reporting antidepressant use, Selective Serotonin Reuptake
Inhibitors (SSRIs), including citalopram, escitalopram, fluoxetine, paroxetine, and sertraline,
were the most common antidepressant medications reported during each time interval (range
45.0% to 65.9%), followed by tricyclic antidepressants (TCAs), including amitriptyline,
desipramine, doxepin, imipramine, and nortriptyline (range 13.1% to 43.8%), and non-SSRI/
non-tricyclic antidepressants, including bupropion, duloxetine, mirtazapine, serzone,
trazodone, and venlafaxine (range 18.8% to 35.2%). The percentage of participants using
SSRIs increased during each subsequent time interval, while the percentage of participants
using TCAs decreased. As shown in Table 2 (first results column), several characteristics
were associated with depression treatment among all participants. With every 1-point
increase in age and MMSE score, the likelihood of being treated decreased by 3% and 11%,
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respectively. In contrast, with every 1-point increase in years of education and CES-D score,
the likelihood of being treated increased by 6% and 3% respectively. Female sex and being
physically frail each were independently associated with a greater likelihood of being
treated. Findings remained consistent when the model was re-run without including
trazodone or amitriptyline as antidepressant medications, with the exception of sex
(OR=1.32, 95% CI 0.97, 1.79) and education (OR=1.05, 95% CI 0.99, 1.11), which were no
longer significantly associated with treatment.
Depression Treatment in the Depressed Participants
A total of 286 (27.9%) participants reported clinically significant depressive symptoms (i.e.,
depressed) at some point during the study period, with 100 (13.3%), 116 (17.2%), 124
(20.3%), 109 (20.2%), 91 (19.3), and 96 (23.2%) participants depressed at baseline, 18, 36,
54, 72, and 90 months, respectively. Of these 286 participants, 158 (55.2%) were depressed
at more than one time point and 142 (49.7%) never reported receiving treatment. As shown
in Figure 2, between 43% and 69% of the depressed participants did not receive any
depression treatment during a specific time interval. These percentages increased after the
exclusion of participants who reported trazodone or amitriptyline as their only treatment,
with values ranging between 48% and 75%. The profile of depression treatment changed
during the follow-up period, with significant increases over time in the percentages of
participants seeing a mental health professional only (p trend=0.01) or receiving both
treatments (p trend <0.001). As shown in Table 2 (second results column), the same
characteristics associated with depression treatment among all participants were also
associated with treatment among the depressed participants, with the exception of sex. In
addition, with the exception of MMSE score, the effect sizes for each of these characteristics
were greater among the depressed participants. The results did not change after the model
was re-run without including trazodone or amitriptyline as antidepressant medications.
Of the 121 participants who were depressed for at least 2 consecutive intervals, indicating
persistent depression, 37 (30.5%) reported receiving no depression treatment. This number
increased to 40 (33.1%) after the exclusion of trazodone and amitriptyline. Among
participants with persistent depression, the likelihood of receiving depression treatment, as
shown in Table 2 (third results column), increased by approximately 32% as the number of
chronic conditions increased and decreased by 9% with every 1-point increase in MMSE
score. Increasing years of education and being physically frail were associated with an
increased likelihood of receiving treatment. However, these latter two characteristics were
no longer significantly associated with treatment after the model was re-run without
including trazodone or amitriptyline as antidepressant medications.
Discussion
In this longitudinal study of older persons, which included multiple assessments of
depressive symptoms and treatment for depression over 9 years, we found that the profile of
depression treatment changed over time, with trends indicating an increase in the use of both
antidepressant medications and a mental health professional. Our findings confirmed
potential under-treatment of depressed older persons. In addition, we also found that many
older persons with persistent depression are not being treated and that patient characteristics,
particularly clinical factors, influence receipt of treatment.
Antidepressant medications have long been the most commonly used treatment for
depression in older persons (Mottram et al., 2006). Although seeing a mental health
professional is also considered to be an effective treatment for depression in this population
(Williams et al., 2000), prior longitudinal studies, with one exception (Unutzer et al., 2003),
have not evaluated use of this treatment modality over time (Mamdani et al., 2000;
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Sonnenberg et al., 2003; Sonnenberg et al., 2008; Wilson et al., 1999). A more inclusive
definition of treatment, such as is used in the present study, likely provides a more complete
picture of the scope of depression treatment among older persons. While the percentage of
participants receiving treatment for depression increased over time, the overall increase was
largely attributable to the rise in the percentage of older persons receiving treatment from a
mental health professional. In fact, we found that the percentage of older persons reporting
antidepressant medication use only steadily decreased over time. These results suggest that
there may be an ongoing shift in how clinicians are treating depression in older persons.
This shift may reflect a diminishing fear of the stigmatization of receiving treatment for
depression that has been previously reported in older persons (Givens et al., 2006; Montano,
1999; Sirey et al., 2001) and perhaps a greater acceptance, by both patients and physicians,
of nonpharmacologic therapy as an effective treatment.
We found that the majority of participants with clinically significant depressive symptoms in
any 18-month interval were not taking an antidepressant medication or receiving treatment
from a mental health professional. This finding is consistent with those of prior studies that
have demonstrated widespread under-treatment of depression in older persons (Garrido et
al., 2011; Sonnenberg et al., 2003; Unutzer et al., 2003; Wilson et al., 1999). While it is
possible that some of the participants, particularly those who were depressed during only
one time interval across the 108-month study period, were being managed appropriately,
strong evidence suggests that under-treatment is often attributable to misrecognition and
under-diagnosis of depression resulting from a combination of physician, patient, and
system-level factors (Mitchell et al., 2010; Park and Unutzer, 2011). Despite the growth of
dedicated geriatric centers in academic medical institutions across the U.S.(Warshaw et al.,
2006), most older persons in this country receive treatment for depression from primary care
physicians in more traditional practices (Crystal et al., 2003; Harman et al., 2006) who often
lack specialty training in geriatric assessment and care (Nutting et al., 2000). Without
expertise in geriatric medicine, physicians may be more likely to misdiagnose depression as
dementia (Wright and Persad, 2007), may mistakenly attribute depressive symptoms as an
acceptable response to aging-related illnesses or conditions (Kennedy and Marcus, 2005), or
may interpret depressive symptoms as an inevitable response to loss of social support and
socialization (Oxman and Hull, 2001). Other factors contributing to the under-diagnosis of
depression in this population include limited time for physicians to discuss mental health
during office visits (Tai-Seale et al., 2007) and older patients’ general reluctance to report
psychological symptoms (Lebowitz et al., 1997; Lyness et al., 1995). Finally, older persons
may be discouraged from seeking mental health-related care by financial considerations.
During our study period, Medicare recipients were required to pay 50% for mental health
services as compared with 20% for physical health conditions. This policy, discriminating
against outpatient mental health services, has recently been rescinded by recent legislation
under the Medicare Improvements for Patients and Providers Act [H.R. 6331; 110th
Congress; July 15, 2008], but is being phased out gradually, with copayments dropping to
20% by 2014. Whether the new policy leads to improved diagnosis and treatment of
depression in older persons should be the focus of future research.
Unlike most prior studies describing depression treatment in older persons (Garrido et al.,
2011; Mamdani et al., 2000; Sonnenberg et al., 2003; Unutzer et al., 2003), the present study
included repeated evaluations of depressive symptoms and treatment. These repeated
assessments enabled us to determine that nearly one third of participants with persistent
depression did not receive treatment. Because we used a conservative approach to define
depression treatment (as described in the Methods), we consequently report the best-case
scenario regarding treatment for depression. Consequently, our findings indicate that there is
still potential opportunity for improved treatment among older persons with persistent
depression. Future studies that evaluate depression treatment, including antidepressant use
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and seeing a mental health professional, among older persons with persistent depression are
needed to corroborate our findings.
Not surprisingly, among all study participants, we found that the likelihood of receiving
treatment for depression increased with increasing CES-D score. Our findings also indicated
that several demographic factors were associated with treatment. Age was inversely
associated with receiving treatment among all participants and among all depressed
participants, but not among those with persistent depression. This inverse association, which
has been reported previously (Sonnenberg et al., 2000; Wang et al., 2005), may be due to
under-recognition of depression as well as factors such as an inability to pay for treatment
among the oldest old or physicians’ concerns regarding antidepressant use and risk of
adverse pharmacologic interactions (Caughey et al., 2010; Hajjar, 2007). Among those with
persistent depression, however, clinicians’ concerns regarding treating increasingly older
patients may be outweighed by their concerns regarding the potentially negative effects of
persistent depression on patients’ health. Education was associated with treatment across all
participants and among the depressed groups, with the likelihood of receiving treatment
increasing with increasing number of years of education. In older persons, a greater number
of years of education has previously been associated with an increased likelihood of taking
antidepressants (Blazer et al., 2005; Sambamoorthi et al., 2003) and seeking treatment for
depression (Nyunt et al., 2009). Once we excluded trazodone and amitriptyline as
antidepressant medications, however, education was no longer associated with treatment in
all participants and in those with persistent depression. More research is needed to
understand if the association between education and treatment is driven by factors such as
income and perception of unmet healthcare needs. Furthermore, the lack of an association
between sex and treatment among all participants (when trazodone and amitriptyline were
not included as antidepressant medications), and among depressed participants as well as
those with persistent depression, challenges prior research indicating that older women are
more likely than older men to receive treatment for depression (Klap et al., 2003; Unutzer et
al., 2003). It is possible that this discordance in findings is attributable to our inability to
distinguish persons with major depressive disorder (MDD) from those who did not meet
criteria for MDD, since prior studies included persons with diagnostically-confirmed
depression. To mitigate this concern, we used a cut-point of 20 or higher on the CES-D,
which increased the likelihood of detecting major depression. It is more likely that the
discordance in findings is attributable to our ability to account for clinical factors, including
cognitive status, number of chronic conditions and physical frailty, which were not
evaluated in prior studies (Klap et al., 2003; Unutzer et al., 2003).
Cognitive impairment, comorbid medical conditions, and physical frailty are highly
prevalent in depressed, older persons (Fischer et al., 2003; Hajjar et al., 2009; Kohler et al.,
2010; Panza et al., 2010), and their omission from most prior studies is a significant
limitation. We found that worsening cognitive status and being physically frail were
consistently associated with a higher likelihood of receiving treatment, and that increasing
number of chronic conditions was associated with an increased likelihood of receiving
treatment among participants with persistent depression. Yet, with few exceptions (Garrido
et al., 2011; Sonnenberg et al., 2008), prior studies have not evaluated the association
between these factors and treatment for depression. Older patients with cognitive
impairment, medical comorbidities, and physical frailty may display more somatic
symptoms of depression than depressed patients without these conditions and, subsequently,
may be more readily prescribed depression treatment. Treatment of older persons with these
conditions, however, is challenging due to their increased risk of adverse drug reactions
(Caughey et al., 2010) and subsequent disability (Fried et al., 2004), which may inhibit
patients’ ability to regularly seek treatment from a mental health professional.
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While the prospective study design provided a unique opportunity to characterize depression
treatment according to depression status over a 9-year period, several potential limitations
should be acknowledged. First, information was not available regarding the diagnosis or
treatment of depression prior to the baseline assessment. Second, we did not have
information regarding the dose, dosing schedule, or adherence for the antidepressant
medication use. Consequently, the percentage of depressed participants who were
undertreated may actually be higher than what is reported in our study due to inadequate
dosing or lack of adherence. Third, information was not available regarding the indication
for antidepressant medication use or the reason for seeing a psychiatrist, psychologist, or
counselor. The use of a rather inclusive definition of depression treatment provides the best
case scenario for the percentage of participants being treated. Finally, because our study
participants were members of a single health plan, initially non-disabled, and at least aged
70 years at baseline, the generalizability of our findings to other older adult populations may
be questioned. However, the demographic characteristics of our study population, including
years of education, closely mirror those of persons 70 years or older in New Haven County,
Connecticut, which, in turn, are comparable to those in the United States as a whole, with
the exception of race. New Haven County has more non-Hispanic whites in this age group
than in the United States (91% versus 84%). Furthermore, generalizability depends not only
on the characteristics of the study population but also on its stability over time (Szklo,
1998). The high participation rate, completeness of data collection, and low rate of attrition
for reasons other than death all enhance the generalizability of our findings and at least
partially offset the absence of a population-based sample.
In conclusion, our findings indicate that the profile of treatment for depression in older
persons has changed over time, particularly with an increase in the combined use of
antidepressant medications and use of a mental health professional. However, despite our
broad definition of treatment for depression, we still found evidence of under-treatment
among depressed, older persons, including those with persistent depression. Our findings
also indicate that clinical factors such as cognitive status, number of chronic conditions, and
physical frailty may influence receipt of treatment in older persons more than factors
previously thought to be associated with treatment in this population, such as increasing age
and female sex. Our work provides a foundation for future longitudinal studies to provide a
more detailed profile of depression treatment in older persons, and evaluate factors
associated with receipt of treatment, while accounting for depression status and indication
for treatment.
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Figure 1.
Profile of depression treatment over 108 months in all study participants. Antidepressant
medication use was ascertained during 18-month face-to-face assessments. Use of a mental
health professional was collected during monthly telephone assessments. If a participant saw
a mental health professional during any of the monthly assessments in a given 18-month
interval (e.g., between the 18-month and 36-month assessments), s/he was coded as having
seen a mental health professional for depression during that interval.
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Figure 2.
Depression treatment over 108 months in the depressed participants. Antidepressant
medication use was ascertained during 18-month face-to-face assessments. Use of a mental
health professional was collected during monthly telephone assessments. If a participant saw
a mental health professional during any of the monthly assessments in a given 18-month
interval (e.g., between the 18-month and 36-month assessments), s/he was coded as having
seen a mental health professional for depression during that interval.
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Table 1
Participant Characteristics.
Characteristic N=754
Age in years, mean (SD) 78.4 (5.3)
Female, n (%) 487 (64.6)
White, n (%) 682 (90.5)
Years of education, mean (SD) 12.0 (2.0)
Number of chronic conditions, mean (SD)* 1.7 (1.2)
Cognitive status, mean (SD) † 26.8 (2.5)
Physical frailty, n (%)‡ 195 (25.7)
Depressed, n (%)§ 100 (13.3)
SD = Standard Deviation
*
Includes 9 self-reported, physician-diagnosed chronic conditions: hypertension, myocardial infarction, congestive heart failure, stroke, diabetes
mellitus, arthritis, hip fracture, chronic lung disease, and cancer (other than minor skin cancer).
†
Assessed by the Mini Mental State Examination (MMSE).
‡
Completed a 10-foot rapid gait walk in >10 seconds.
§
Score ≥ 20 on the Center for Epidemiological Studies - Depression (CES-D) scale.
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